Established in 1934, The Bagó Group is Argentina's premier pharmaceutical group, with consolidated sales of over US $ 1 Billion. The group comprises different companies focused on human health, animal Health, and pharmaceutical distribution.
The Bagó Group companies have achieved a leading position in the markets in Latin America, North America, Europe and Asia, with a combined workforce of 4800 people, all working with a shared commitment towards improving health worldwide. Ferozsons and Bagó entered into commercial partnership in 2002 to launch the Bago range of quality branded generics in the field of oncology and hepatology in Pakistan. Within the first two years, together we achieved a leadership position, becoming one of the top 3 companies in both Oncology and hepatology segments.
In December 2004, Bagó and Ferozsons signed agreed in principle to enter into a joint-venture in Pakistan. The agreement to form BF Biosciences Limited, Pakistan's first biotech formulation company was signed in 2006. The plant, which has been built on a 27 acre site in Lahore, Pakistan, was completed in 2009 and manufactures biological medicines to treat Cancer and Hepatitis C for the local and export markets.
The joint-venture has put Pakistan on the map of countries with biotech manufacturing capacity. As the first USFDA compliant pharmaceutical facility in the country, we have also helped Pakistan join the select group of companies that are exporting biotech pharmaceuticals. Exports have already commenced to Asian Markets.